Everolimus for advanced breast cancer: Is the histological subtype important?

被引：0
|
作者：
Vargas, Alicia
Flores Paco, Pablo
De La Haba, Juan
Morales-Estevez, Cristina
Rodriguez-Alonso, Beatriz
Porras, Ignacio
de la Cruz-Merino, Luis
Munoz, Clara
Lorente, Margarita
Gonzalez Flores, Encarnacion
Sanchez-Rovira, Pedro
Arenas, Rafael
Armenta, Ana
Aranda, Enrique
机构：
[1] Univ Reina Sofia Hosp, Cordoba, Spain
[2] Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain
[3] Univ Cordoba, Univ Reina Sofia Hosp, Cordoba, Spain
[4] GEICAM Spanish Breast Canc Grp, Cordoba, Spain
[5] Hosp Univ Virgen Macarena, Seville, Spain
[6] Virgen Macarena Univ Hosp, Seville, Spain
[7] Virgen de las Nieves Univ Hosp, Granada, Spain
[8] Virgen de las Nieves Hosp, Granada, Spain
[9] Hosp Univ Jaen, Jaen, Spain
[10] GEICAM Spanish Breast Canc Grp, Jaen, Spain
[11] Univ Reina Sofia Hosp, Dept Med Oncol, Cordoba, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13165
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Breast Cancer Subtype and Locoregional Outcomes in Locally Advanced Breast Cancer
    Verma, J.
    Kwon, D.
    Reis, I. M.
    Takita, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S263 - S263
  • [2] The Influence of Histological Subtype on The Accuracy of Axillary Ultrasound in Breast Cancer
    O'Beirn, E.
    Moloney, B.
    McLaughlin, R.
    Sweeney, K.
    Malone, C.
    Kerin, M. J.
    Lowery, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (SUPPL 5) : S124 - S125
  • [3] Breast Cancer Subtype and Locoregional Outcomes in Locally Advanced Breast Cancer (LABC)
    Takita, C.
    Ferrell, A.
    Walker, G.
    Wright, J. L.
    Gunaseelan, V.
    Wahab, M. A.
    Wolfson, A. H.
    Markoe, A. M.
    Mahmoud, O.
    Pollack, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S212 - S212
  • [4] Histological subtype is the most important determinant of survival in metastatic papillary thyroid cancer
    Chrisoulidou A.
    Boudina M.
    Tzemailas A.
    Doumala E.
    Iliadou P.K.
    Patakiouta F.
    Pazaitou-Panayiotou K.
    Thyroid Research, 4 (1)
  • [5] Everolimus in first-line treatment of advanced premenopausal breast cancer: Results from MIRACLE (everoliMus trIal foR AdvanCed premenopausaL brEast cancer) study
    Fan, Ying
    Sun, Tao
    Shao, Zhimin
    Zhang, Qingyuan
    Ouyang, Quchang
    Tong, Zhongsheng
    Wang, Shusen
    Luo, Yang
    Teng, Yuee
    Wang, Xiaojia
    Wang, Shu
    Liu, Qiang
    Feng, Jifeng
    Shen, Kunwei
    Song, Yanqiu
    Wang, Jiayu
    Ma, Fei
    Li, Qing
    Zhang, Pin
    Xu, Binghe
    CANCER RESEARCH, 2020, 80 (04)
  • [6] Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer
    Davidson, Michael
    Chau, Ian
    Cunningham, David
    Khabra, Komel
    Iveson, Timothy
    Hickish, Tamas
    Seymour, Matthew
    Starling, Naureen
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (08) : 333 - 340
  • [7] Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer
    Michael Davidson
    Ian Chau
    David Cunningham
    Komel Khabra
    Timothy Iveson
    Tamas Hickish
    Matthew Seymour
    Naureen Starling
    World Journal of Gastrointestinal Oncology, 2017, (08) : 333 - 340
  • [8] Everolimus in HR-Positive Advanced Breast Cancer REPLY
    Baselga, Jose
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (18): : 1739 - 1740
  • [9] Breast Cancer Subtype Classification from Computational Histological Image Analysis
    Zarella, M. D.
    Greenfield, B.
    Yan, J.
    Breen, D. E.
    Garcia, F. U.
    MODERN PATHOLOGY, 2014, 27 : 404A - 404A
  • [10] Breast Cancer Subtype Classification from Computational Histological Image Analysis
    Zarella, M. D.
    Greenfield, B.
    Yan, J.
    Breen, D. E.
    Garcia, F. U.
    LABORATORY INVESTIGATION, 2014, 94 : 404A - 404A
12345